EpidStrategies A Division of ToxStrategies Revenue and Competitors

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • EpidStrategies A Division of ToxStrategies's estimated annual revenue is currently $21.7M per year.(i)
  • EpidStrategies A Division of ToxStrategies's estimated revenue per employee is $201,000

Employee Data

  • EpidStrategies A Division of ToxStrategies has 108 Employees.(i)
  • EpidStrategies A Division of ToxStrategies grew their employee count by -4% last year.

EpidStrategies A Division of ToxStrategies's People

NameTitleEmail/Phone
1
Senior Statistician IIReveal Email/Phone
2
Senior ConsultantReveal Email/Phone
3
Senior EpidemiologistReveal Email/Phone
4
Supervising EpidemiologistReveal Email/Phone
5
Supervising StatisticianReveal Email/Phone
6
Senior Epidemiologist IIReveal Email/Phone
7
Epidemiologist IIIReveal Email/Phone
8
Senior EpidemiologistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$6.2M31-11%N/AN/A
#2
$2.6M130%N/AN/A
#3
$6.8M34-6%N/AN/A
#4
$5.8M29-44%N/AN/A
#5
$405.4M201718%N/AN/A
#6
$29.9M1499%N/AN/A
#7
$127.4M63419%N/AN/A
#8
$15.5M7726%N/AN/A
#9
$35.2M1754%N/AN/A
#10
$30.4M151-3%N/AN/A
Add Company

What Is EpidStrategies A Division of ToxStrategies?

EpidStrategies is founded on rigorous scientific principles that guide our research on complex health conditions. With a focus on pharmaceuticals, medical devices, and environmental chemicals, our scientists aid clients in the conduct, evaluation, and interpretation of epidemiological studies. Our research frequently results in peer-reviewed publications and presentations at scientific conferences, as well as being used in numerous regulatory documents in the US and Europe.

keywords:N/A

N/A

Total Funding

108

Number of Employees

$21.7M

Revenue (est)

-4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$35.3M1104%N/A
#2
$24.4M11141%N/A
#3
$16.7M111-1%N/A
#4
$16.2M1128%N/A
#5
$16.4M113-3%N/A